arrow
H

Hongjun Bai

Henry M. Jackson Foundation
H指数:20
被引数:1,721

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials

抗体介导预防试验中,使用广谱中和抗体VRC01进行预防性治疗会在感染后选择逃逸突变体

2026-09-280
OA
VRC01 Exerted Differential Pressure on HIV-1 Envelope From Subtypes B and C That Continued in the First Weeks Postdiagnosis in the Antibody Mediated Prevention Trials

VRC01 对 B 和 C 亚型 HIV-1 包膜施加的差异压力在抗体介导的预防试验中确诊后的前几周持续存在

2026-09-080
OAAI
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

在抗体介导的预防试验中,广泛中和抗体VRC01对HIV突破性病毒人群的影响

2026-04-030
OAAI
Extended in vivo activity of VRC01 HIV-1 prophylaxis entails initial protective efficacy and subsequent breakthrough infections

VRC01 HIV-1预防性治疗的体内持续活性涉及初始保护效果及后续突破性感染

2026-01-010
OA
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa

东非生活于HIV-1亚型A1的女性中,高病毒血症后出现自发性HIV-1控制。

2025-08-100
OAAI
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification
2024-09-020
OAAI
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding
2024-05-090
OAAI
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
2024-03-112
OAAI
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

广泛中和抗体VRC01的预防功效取决于HIV-1的包膜序列特征

2024-01-194
OAAI
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
2024-01-033
OAAI
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopes
2023-08-017
OAAI
Targeting the Spike Receptor Binding Domain Class V Cryptic Epitope by an Antibody with Pan-Sarbecovirus Activity
2023-07-2712
OAAI
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
2023-02-0316
OAAI
Long-term antiretroviral therapy initiated in acute HIV infection prevents residual dysfunction of HIV-specific CD8+ T cells

在急性HIV感染中开始的长期抗逆转录病毒治疗可防止HIV特异性CD8 T细胞的残留功能障碍

2022-10-0118
OAAI
HIV-1 infections with multiple founders associate with the development of neutralization breadth
2022-03-187
OAAI
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth
2021-08-102
OAAI
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
2021-07-093
OAAI